APA (7th ed.) Citation

H, S., AD, F., L, P., TT, Y., J, M., A, Z., . . . W, J. (2019). The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. Journal of cellular and molecular medicine, 23(3), 1759. https://doi.org/10.1111/jcmm.14074

Chicago Style (17th ed.) Citation

H, Schilter, et al. "The Lysyl Oxidase like 2/3 Enzymatic Inhibitor, PXS-5153A, Reduces Crosslinks and Ameliorates Fibrosis." Journal of Cellular and Molecular Medicine 23, no. 3 (2019): 1759. https://doi.org/10.1111/jcmm.14074.

MLA (9th ed.) Citation

H, Schilter, et al. "The Lysyl Oxidase like 2/3 Enzymatic Inhibitor, PXS-5153A, Reduces Crosslinks and Ameliorates Fibrosis." Journal of Cellular and Molecular Medicine, vol. 23, no. 3, 2019, p. 1759, https://doi.org/10.1111/jcmm.14074.